Journal
JOURNAL OF CONTROLLED RELEASE
Volume 183, Issue -, Pages 94-104Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2014.03.022
Keywords
Nanomedicine; Pulmonary drug delivery; Hydrophobicity; Nanotoxicology; Polystyrene; Lipid nanocapsules
Funding
- UK Medical Research Council [G0900953]
- MRC [G0900953] Funding Source: UKRI
- Medical Research Council [G0900953] Funding Source: researchfish
- National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) [NC/C013109/1, NC/C013203/1] Funding Source: researchfish
Ask authors/readers for more resources
To date, the role of nanoparticle surface hydrophobicity has not been investigated quantitatively in relation to pulmonary biocompatibility. A panel of nanoparticles spanning three different biomaterial types, pegylated lipid nanocapsules, polyvinyl acetate (PVAc) and polystyrene nanoparticles, were characterized for size, surface charge, and stability in biofluids. Surface hydrophobicity of five nanoparticles (50-150 nm) was quantified using hydrophobic interaction chromatography (HIC) and classified using a purpose-developed hydrophobicity scale: the HIC index, range from 0.00 (hydrophilic) to 1.00 (hydrophobic). This enabled the relationship between the nanomaterial HIC index value and acute lung inflammation after pulmonary administration to mice to be investigated. The nanomaterials with low HIC index values (between 0.50 and 0.64) elicited little or no inflammation at low (22 cm(2)) or high (220 cm(2)) nanoparticle surface area doses per animal, whereas equivalent surface area doses of the two nanoparticles with high HIC index values (0.88- 0.96) induced neutrophil infiltration, elevation of pro-inflammatory cytokines and adverse histopathology findings. In summary, a HIC index is reported that provides a versatile, discriminatory, and widely available measure of nanoparticle surface hydrophobicity. The avoidance of high (HIC index > -0.8) surface hydrophobicity appears to be important for the design of safe nanomedicines for inhalation therapy. (C) 2014 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available